Sanger Sequencing Industry Growth Insights: Revenue Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the sanger sequencing market from 2026–2035 with trusted insights from The Business Research Company
What long-term size projections exist for the Sanger Sequencing Market covering 2026–2035?
The market size for sanger sequencing has shown rapid growth in recent years. Forecasts indicate it will increase from $3.29 billion in 2025 to $3.85 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. Historically, this expansion has stemmed from factors such as the initial widespread acceptance of sanger sequencing as the benchmark method, a rise in genomics research by academic institutions and governments, an increase in genetic disorder screening, broader application in forensic analyses, and heightened pharmaceutical research and development efforts.
The sanger sequencing market is poised for substantial expansion in the coming years, with projections indicating it will reach $7.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.7%. This anticipated growth during the forecast period can be attributed to the ongoing necessity for confirmatory sequencing alongside NGS, the expansion of personalized medicine applications, an increasing demand for cost-effective targeted sequencing, the growth of clinical diagnostics in emerging markets, and elevated collaborations between biotech firms and research institutes. Key trends over the forecast period include the sustained use of sanger sequencing for the validation of NGS results, a steady demand for targeted gene sequencing in diagnostics, its growing application in biomarker and cancer research, the increasing outsourcing of sequencing services to specialized laboratories, and its continued adoption in forensics and reproductive health testing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp
Which Drivers Are Impacting The Competitive Landscape Of The Sanger Sequencing Market?
The sanger sequencing market is anticipated to grow propelled by the rising incidence of genetic illness. A genetic illness, also referred to as a genetic disorder, constitutes a medical condition stemming from abnormalities or mutations in an individual’s DNA, which serves as the hereditary material carrying genetic information. Sanger sequencing is utilized to diagnose genetic illnesses by ascertaining the precise order of nucleotides (the constituent building blocks of DNA) within a specific gene or a particular region of DNA. For instance, in August 2024, as per the National Health Service, a UK-based publicly funded healthcare system, approximately 2,300 individuals in the UK are living with thalassaemia as of 2024. Among these, around 800 have the severe form of the condition and rely on regular blood transfusions. Hence, the increase in genetic illness is stimulating the growth of the sanger sequencing market.
What Segments Are Identified Within The Structure Of The Sanger Sequencing Market?
The sanger sequencing market covered in this report is segmented –
1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory: Wet Labs, Dry Labs
3) By Research: In-House, Outsourced
4) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics
Subsegments:
1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing
2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing
3) By Other Sequencing: Nested PCR Sequencing, Capillary Electrophoresis Based Sanger Sequencing
Which Trends Are Expected To Influence The Sanger Sequencing Market In The Upcoming Years?
Major companies active in the sanger sequencing market are focusing on expanding genomic laboratories to provide rapid sanger sequencing services to the North of the UK. Genomic laboratories are specialized facilities that carry out genetic testing and analysis to study the structure, function, and inheritance of genes and genomes, often for purposes such as diagnosis, research, and personalized medicine. For instance, in June 2023, Source Genomics, a UK-based company offering genomic services, announced the expansion of their genomic laboratory into the UK’s north. This extension is set to enhance the capacity of their Sanger sequencing services and accelerate data delivery turnaround times. Broadening laboratory operations to the northern territories signifies a major advancement in providing equitable access to genomic services for research organizations nationwide. This geographical growth will enable customers across the country to benefit from top-quality Sanger sequencing services with quicker turnaround times.
Which Key Market Players Are Investing In Expansion And Innovation Within The Sanger Sequencing Market?
Major companies operating in the sanger sequencing market are Hoffmann La Roche, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific, Beckman Coulter, PerkinElmer Inc, LGC Limited, GenScript, Macrogen Inc, GENEWIZ Inc, Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty Ltd, SciGenom Labs Pvt Ltd, StarSEQ GmbH, GATC Biotech AG, Agilent Technologies, Azenta Life Sciences, CD Genomics, Novogene Sanger Services
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report
Which Regions Are Poised For Strategic Growth In The Sanger Sequencing Market?
North America was the largest region in the sanger sequencing market in 2025. The regions covered in the sanger sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Sanger Sequencing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13925&type=smp
Browse Through More Reports Similar to the Global Sanger Sequencing Market 2026, By The Business Research Company
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Short Read Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
